Figure 2From: Characterization of the bronchodilatory dose response to indacaterol in patients with chronic obstructive pulmonary disease using model-based approachesImprovement in trough FEV 1 (mL) with indacaterol 150 μg observed at different days in six of the studies in the study-level analysis ranked by median value.Back to article page